Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Synthesis and Evaluation of a Novel Nanosized Anionic Linear Globular Dendrimer G2-Ciprofloxacin Conjugate Against Prostate Cancer Publisher Pubmed



Teyhoo M1 ; Hosseini F1 ; Ardestani MS2 ; Ghorbani M3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Microbiology, Islamic Azad University, Tehran North Branch, Tehran, Iran
  2. 2. Department of Radiopharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Pasteur Institute of Iran, Research and Production Complex, Kilometre 25 Autobahn Karaj, Alborz, Iran

Source: Pakistan Journal of Pharmaceutical Sciences Published:2020


Abstract

Prostate cancer is the second most common cancer in the world and the fifth cause of cancer deaths in men. Ciprofloxacin enables the inhabitation of the development of prostate cancer. In this regard, we plan to improve the anticancer effect of ciprofloxacin using the anionic G2 dendrimer in conjunction with ciprofloxacin. In the current study, we measured the size and the zeta potential as well as LC Mass to prove the fact that the conjugation was synthesized correctly. The anticancer activity among three groups including Ciprofloxacin, Ciprofloxacin -G2 dendrimer, and control was measured in vitro. In vitro studies showed that G2 anionic linear-globular polyethylene-glycol-based dendrimer, which conjugated to ciprofloxacin, was able to significantly improve the treatment efficacy over clinical ciprofloxacin alone with respect to proliferation assay. Maximal inhibitory concentration (IC50) was calculated as 200 μg/mL for ciprofloxacin alone and 30μg/mL for ciprofloxacin-G2 dendrimer. In addition, the growth of DU-145 cancerous cells was inhibited by ciprofloxacin-G2 dendrimer conjugate and the number of apoptotic and necrotic cells was increased significantly as evaluated by an annexin V-fluorescein isothiocyanate assay. Ciprofloxacin -G2 dendrimer conjugate was able to increase Bcl-2/Bax ratio in a large scale as compared with the control group and CBL alone. According to the above results, this compound could be considered as a good candidate for functional cancer treatment with low side effects. © 2020 Pakistan Journal of Pharmaceutical Sciences. All rights reserved.
Other Related Docs
10. Evaluation of Serum Vitamin B12 Levels in Patients With Colon and Breast Cancer: A Case-Control Study, International Journal of Hematology-Oncology and Stem Cell Research (2023)